Articles tagged with Eye Diseases
The ARVO Foundation for Eye Research recognizes six clinicians with innovative vision research projects. Maria Cristina Malloci and others receive grants to support their work on AMD, ocular surface infections and corneal diseases.
A global study estimates that 60.5 million people will have glaucoma by 2010, with 3 out of 4 cases being open angle glaucoma. By 2020, this number is projected to reach 80 million, mostly affecting women and people from Asia. The disease will also increase rapidly in India, causing significant blindness worldwide.
Researchers found that glaucoma patients have higher intraocular pressure when lying down compared to sitting. The study measured the pressure of 148 untreated glaucoma patients over 24 hours, revealing a significant difference in peak pressures between daytime and nighttime measurements.
A study published in Archives of Ophthalmology found that patients with end-stage glaucoma consume approximately $2,511 per year in healthcare resources, compared to $623 for those with early-stage disease. Effective treatments at earlier stages can slow or halt disease progression, saving both patients and society from greater economi...
The study found that direct ophthalmology-related resource use increased with disease severity, resulting in higher costs. The average direct cost of treatment ranged from $623 to $2,511 per patient per year, with medication costs being the largest proportion of total direct cost.
Case Western Reserve University professor Eric Pearlman has received a prestigious vision research grant to study the immunology of the eye. The grant will help researchers understand the immunological basis of diseases such as age-related macular degeneration and diabetic retinopathy.
Researchers found that passive smoking significantly increases the risk of age-related macular degeneration, with pack years of cigarette smoke being a major determinant. Regularly smoking for 40 years or more can almost triple this risk compared to non-smokers.
A study found that visually impaired individuals prefer TV content enhanced to their individual contrast settings, improving image visibility. The device aims to simplify design and enhance the viewing experience for both impaired and sighted viewers alike.
Researchers used in vivo cell fate mapping to study the role of TGFbeta signaling in congenital eye disorders. They found that NC-derived cells contribute to various eye structures, and TGFbeta signaling is essential for their proper differentiation and morphogenesis.
Research suggests that a diet rich in omega-3 fatty acids, found in fish and walnuts, may help prevent dry eye syndrome. Women who consumed at least five servings of tuna per week had a 68% reduced risk of the condition compared to those with lower intakes.
A new mathematical model developed by researchers at Imperial College London can help reduce the numbers affected by river blindness. The model measures exposure by analyzing how often people were bitten by flies carrying the parasite, providing a better understanding of the role of exposure in the fight against the disease.
A novel genetic testing tool has been developed to screen for multiple retinal disease genes on a single microchip, offering faster and more accurate diagnoses for conditions like RP. The arRP-I chip is 23% less expensive than current sequencing methods and can detect both known and novel mutations.
Researchers found that 97% of patients achieved control over ocular inflammation after one month of treatment with the new drug. Additionally, 82% were able to taper their dose of steroid prednisone without experiencing increased side effects.
Researchers have discovered a genetic finding that may hold the key to unlocking treatments for farsightedness and nearsightedness. The MFRP protein, found in a rare eye disorder called nanophthalmos, regulates eye growth and refraction, making it a promising target for correcting severe refractive errors.
Scientists at the University of Florida have developed a gene therapy that prevents blindness in mice with retinoschisis, a rare genetic disorder. The treatment involves injecting a healthy version of the human RS1 gene to prevent cyst formation and restore vision in affected eyes.
Studies have pinpointed a chromosome region and genetic markers for macular degeneration in humans and rhesus monkeys. This breakthrough could lead to better treatments and even a cure by studying the disease's progression in monkeys, which age faster than humans.
The Eye Saver provides 40 percent more surface illumination on work and reading surfaces, reducing eyestrain by lowering glare. This innovative light bulb is suitable for people of all ages and particularly useful for those afflicted with age-related macular degeneration.
Researchers discovered a protein in the eye that prevents the immune system from responding to foreign invaders, protecting delicate tissue. The F4/80 molecule plays a crucial role in 'immune privilege,' preventing inflammation and immune activation in privileged sites.
A study found high rates of untreated eye disease among older adults with diabetes, particularly in managed care networks. Managed care patients were more likely to have cataract and glaucoma, highlighting the need for improved access to eye care.
A new study has found that older patients with type 2 diabetes often go without necessary eye care. According to the research, approximately 42% of managed care patients and 28% of fee-for-service patients require urgent treatment for treatable eye conditions within six months.
This May 2005 Ophthalmology journal issue presents multiple research findings on various ophthalmic conditions, including temporal arteritis, isolated optic atrophy, diabetic retinopathy, and uveitis. Key studies explore the management of neurological disorders and treatment outcomes for patients with these conditions.
A Columbia University/University of Iowa study reveals that inherited variations in the Factor H gene may trigger age-related macular degeneration through inflammation and immune responses. Researchers found that targeting molecules involved in immune system response could lead to powerful new therapies for treating and preventing AMD.
Treatment improved vision in older children with amblyopia, with 53% of age seven-12 year olds showing significant improvement when treated with glasses and patches. Most children were left with some visual impairment despite treatment.
A new painless diagnostic test for Sjögren's syndrome could be available in two to three years, promising faster diagnosis and reduced severity of symptoms. The test involves analyzing teardrops collected from patients' eyes, which may help identify specific protein biomarkers for the disease.
Researchers found that clear display conditions improve human vision learning, allowing for optimal training of individuals with lazy eye or related disorders. The study suggests that each eye should be trained separately in clear displays for maximum benefit.
The study found a strong risk factor for AMD, caused by a single nucleotide polymorphism in the complement factor H gene. The genetic variation alters a protein that regulates the immune system's attack on foreign invaders and abnormal cells.
Researchers have identified a gene mutation in Complement Factor H as a key factor in the development of age-related macular degeneration. This complex disease affects millions of Americans, with family history being a significant risk factor.
Researchers at the University of Utah Health have created a genetically engineered mouse model that closely mimics age-related macular degeneration and Stargardt disease. The study provides a promising platform for testing treatment strategies such as cell transplantation, gene therapy, and pharmaceuticals.
A structured group session improved quality of life, mood, and function in AMD patients after six months. The program also prevented depression cases and increased participants' confidence in their physical abilities.
The study demonstrates a statistically significant and clinically meaningful benefit of pegaptanib in treating wet AMD. Treatment with pegaptanib reduces the risk of visual-acuity loss, promotes stability of vision, and may lead to more visual improvement in some patients.
Columbia University Irving Medical Center affiliate Harlem Hospital Center will fund aggressive screening program for glaucoma, which disproportionately affects African Americans. The hospital has demonstrated an impressive job in screening the community for this devastating condition.
A University of Utah study suggests that a type of cellular waste may be responsible for a form of blinding eye disease called retinitis pigmentosa. The researchers found that a mutation in the carbonic anhydrase 4 gene can lead to photoreceptor degeneration, highlighting the potential for new treatments targeting this process.
A study by University of Utah vision researchers identified a single gene mutation causing Beehive Syndrome, a rare eye disease with symptoms including optic atrophy, deafness, and ptosis. The discovery could lead to greater diagnoses and treatments for patients with the condition.
A study of 1,148 hypertensive patients with type 2 diabetes found that tight blood pressure control reduced the incidence of diabetic retinopathy and visual loss by 47% over seven years. The researchers discovered a lower risk of microaneurysms and blindness in the tight BP control group compared to those with less stringent policies.
Researchers will pinpoint the genetic cause of Thiel-Behnke, a rare corneal dystrophy, using a $1.1 million NEI grant. The study aims to improve diagnosis and treatment options for other types of corneal dystrophies.
Researchers found that atropine eye drops administered two days a week are as effective as daily drops or an eye patch in treating amblyopia. This reduces hassle for young patients, enabling better vision development.
A clinical trial found that daily and weekend administration of atropine sulfate eye drops have similar improvement in children with amblyopia, a condition affecting 3% of US children. The study suggests weekend drops may relieve parent burden while encouraging treatment compliance.
A growing epidemic of wet AMD is expected to double diagnoses by 2020, with new treatments in late-phase clinical trials or pending FDA approval showing promise for stabilizing the disease and preserving vision. Innovations in biotechnology offer new options for patients, including anti-VEGF, anti-angiogenic, and angiostatic treatments.
Researchers successfully transplanted human retinal stem cells into light-sensing photoreceptor cells and retinal pigment epithelial cells in animal models. The study's findings have implications for future treatment of degenerative eye diseases such as retinitis pigmentosa and macular degeneration.
The study confirms that patients benefit from two years of treatment with Macugen for wet AMD, demonstrating a statistically significant 45% treatment benefit. Longer-term use may be beneficial for patients suffering from this chronic disease.
The Schepens Eye Research Institute will combine forces with experts from other biomedical and technological fields to develop a center for curing eye diseases, including age-related macular degeneration and diabetic retinopathy. The three-year grant will fund the planning and piloting phase of an interdisciplinary research center.
A new technique using spectral imaging allows doctors to detect and chart eye diseases such as diabetic retinopathy and glaucoma with high accuracy. The method uses liquid crystal tuneable filters and cooled digital cameras to take images at specific wavelengths, revealing the oxygenation state of blood vessels in the eye.
This September 2004 issue of Ophthalmology journal features groundbreaking research on predictive factors for glaucomatous visual field progression, primary open-angle glaucoma in Japan, and hypothyroidism's impact on open-angle glaucoma. The studies also explore the mechanism of ocular hypotensive action of bimatoprost and optic nerve...
The study reveals alarming rates of eye diseases among Latinos, including open-angle glaucoma, diabetic retinopathy, and cataracts. These findings underscore the importance of developing tailored prevention and treatment strategies for this underserved population.
A new study by USC researchers reveals high levels of visual impairment and eye disease among Latinos, with nearly one in four participants having diabetes and nearly half showing signs of diabetic retinopathy. The study also found that open-angle glaucoma and ocular hypertension were prevalent among the Latino population.
A comprehensive study found that US Latinos have high rates of diabetic retinopathy, open-angle glaucoma, and cataract, with significant disparities in healthcare access. Researchers emphasize the importance of providing culturally tailored programs to detect and manage eye diseases in this population.
The American Academy of Ophthalmology published significant studies in the July 2004 issue, shedding light on innovative treatments and technologies for various eye conditions. These groundbreaking findings have the potential to transform the field of ophthalmology and improve patient outcomes.
A study reveals that 97% of infertile couples and 80% of the general population believe PGD should be permitted for detecting genetic diseases. The majority also oppose reproductive cloning, with only 7% in favour. Germans demand change in German Embryo Protection Law to allow PGD.
A recent study found that fruit consumption was inversely associated with risk of neovascular ARM, a more severe type of vision loss. Participants who ate three or more servings per day had a 36% lower risk compared to those eating less than 1.5 servings.
African American participants who received pressure-lowering eye drops had a lower risk of developing glaucoma compared to those who didn't receive treatment. Regular eye exams are crucial for determining glaucoma risk, particularly in African Americans over 40.
A new study published in Archives of Ophthalmology suggests that daily eye drops can significantly reduce the development of primary open-angle glaucoma in African Americans by nearly 50%. The study recommends periodic eye exams starting at age 40 for high-risk individuals.
The study found that daily pressure-lowering eye drops reduced the development of primary open-angle glaucoma in African Americans by almost 50%. This suggests that comprehensive dilated eye examinations should be recommended at least once every two years for African Americans over age 40.
This June 2004 Ophthalmology Journal issue presents various studies on retinal detachment, glaucoma valve implantation, and age-related maculopathy. The efficacy and safety of adjunctive Mitomycin C during Ahmed Glaucoma Valve Implantation are also examined.
Glaucoma is a group of disorders that progressively damage the optic nerve, affecting 66 million people worldwide. Early detection through comprehensive eye assessments, including optic disc examination, is crucial for limiting vision loss and advancing treatment. Current therapies can limit vision loss if identified in early stages.
Researchers have identified six essential genes for cilia formation in humans, which could help diagnose and treat diseases such as infertility, pulmonary diseases, and vision problems. The discovery provides a critical new tool for medical researchers to understand the genetic basis of these disorders.
Researchers from the National Eye Institute investigated the association between various types of visual impairment and eye disorders with mortality. The study found that participants with AMD had a 41% higher risk of death compared to those with little or no drusen, while advanced AMD was associated with cardiovascular deaths.
A study estimates that 937,000 Americans are blind, with white persons affected by age-related macular degeneration. The prevalence of visual impairment is expected to increase due to aging, with blacks and Hispanics more likely to be affected by cataracts and glaucoma.
The Eye Diseases Prevalence Research Group has conducted large, population-based studies to determine the prevalence of cataract, age-related macular degeneration, diabetic retinopathy, and other eye disorders. The estimates are likely to be reliable and available without waiting many years and spending tens of millions of dollars.
The study projects that vision loss from eye diseases will reach 5.5 million Americans by 2020, with age-related macular degeneration, glaucoma, and cataract being the most common causes. Regular comprehensive eye exams are crucial for preventing and/or delaying eye disease in those at higher risk.
A study by the Eye Diseases Prevalence Research Group found that approximately two-fifths of persons aged 40 and older with DM are affected by diabetic retinopathy, while one in twelve have reached a vision-threatening stage. The prevalence rates were estimated using data from eight population-based eye surveys.